IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $5 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $5 | $6 |
| Operating Income | -$3 | -$3 | -$5 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$3 | -$1 | $0 |
| Pre-Tax Income | -$5 | -$6 | -$6 | -$5 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS | -0.31 | -0.49 | -0.49 | -0.5 |
| % Growth | 36.7% | 0% | 2% | – |
| EPS Diluted | -0.31 | -0.49 | -0.49 | -0.5 |
| Weighted Avg Shares Out | 17 | 13 | 12 | 11 |
| Weighted Avg Shares Out Dil | 17 | 13 | 12 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$4 | -$5 | -$6 |
| % Margin | – | – | – | – |